Regulatory Case Study: The Role of Clinical Biomarkers in the Development of Gene Therapies
Time: 10:00 am
day: Conference Day One pt 1
Details:
• Biomarkers relevant to disease progression that support the differentiation of gene therapies
• Biomarkers as key endpoints for accelerated approval of gene therapies
• Innovative approaches in biomarker discovery for gene therapies
